Scynexis (SCYX) Revenue Growth (5y) (2018 - 2024)
Scynexis (SCYX) Revenue Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 66.80% |
| Mar 31, 2024 | 84.63% |
| Dec 31, 2023 | 146.27% |
| Sep 30, 2023 | 94.05% |
| Jun 30, 2023 | 359.75% |
| Mar 31, 2023 | 77.57% |
| Dec 31, 2022 | 88.52% |
| Sep 30, 2022 | 89.33% |
| Jun 30, 2022 | 83.26% |
| Mar 31, 2022 | 61.36% |
| Dec 31, 2021 | 55.82% |
| Sep 30, 2021 | 51.81% |
| Mar 31, 2021 | 185.08% |
| Jun 30, 2019 | -2.59% |
| Mar 31, 2019 | -53.31% |
| Dec 31, 2018 | -62.93% |
| Sep 30, 2018 | -56.61% |
| Jun 30, 2018 | -51.58% |
| Mar 31, 2018 | -57.82% |